Glaxo (GSK), SK bioscience's COVID-19 Jab Enters Phase III Study

Published on September 1, 2021

GlaxoSmithKline (GSK) and SK bioscience begin a phase III study on GBP510, the latter's COVID-19 vaccine candidate. The study will compare GBP510 agai...

Continue reading on website
Other news

3 Reasons Why Reliance Steel (RS) Is a Great Growth Stock

September 1, 2021
Reliance Steel (RS) could produce exceptional returns because of its solid growth attributes.

Reasons to Retain H&R Block (HRB) Stock in Your Portfolio

September 1, 2021
H&R Block's (HRB) Block Horizons strategy is expected to help the company deliver sustainable revenues and operating profit growth.